L. Ngo

Title HER 2 amplification and clinicopathological characteristicsin a large Asian cohort of rare mucinous ovarian cancer

S. Lim-Tan, I. Busmanis, W. Ong, 2017 .

HER2 Amplification and Clinicopathological Characteristics in a Large Asian Cohort of Rare Mucinous Ovarian Cancer

S. Lim-Tan, I. Busmanis, W. Ong, 2013, PloS one.

Efficacy of low-dose ketoconazole in hormone refractory prostate cancer patients at the National Cancer Centre and The Cancer Institute, Singapore.

L. Ngo, M. Tay, A. Yeo, 2007, Annals of the Academy of Medicine, Singapore.

Comparative analysis of extra‐nodal NK/T‐cell lymphoma and peripheral T‐cell lymphoma: significant differences in clinical characteristics and prognosis

M. Tan, S. Hee, M. Ang, 2007, European journal of haematology.

Prognostic factors in patients with diffuse large B cell lymphoma: Before and after the introduction of rituximab

M. Tan, S. Hee, M. Ang, 2008, Leukemia & lymphoma.

A large multicentre, randomized, double‐blind, cross‐over study in healthy volunteers to compare pharmacokinetics, pharmacodynamics and safety of a pegfilgrastim biosimilar with its US‐ and EU‐reference biologics

C. Schelcher, Jessie Wang, A. Bellon, 2020, British journal of clinical pharmacology.

Uterine leiomyosarcoma in asian patients: validation of the revised Federation of gynecology and obstetrics staging system and identification of prognostic classifiers.

S. Lim-Tan, I. Busmanis, W. Ong, 2012, The oncologist.